Log in

CVE:APOACASTI PHARM-TS Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive APO News and Ratings via Email

Sign-up to receive the latest news and ratings for APO and its competitors with MarketBeat's FREE daily newsletter.

ACASTI PHARM-TS (CVE:APO) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of ACASTI PHARM-TS?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ACASTI PHARM-TS in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ACASTI PHARM-TS.

When is ACASTI PHARM-TS's next earnings date?

ACASTI PHARM-TS is scheduled to release its next quarterly earnings announcement on Wednesday, June 24th 2020. View our earnings forecast for ACASTI PHARM-TS.

Has ACASTI PHARM-TS been receiving favorable news coverage?

News stories about APO stock have been trending very negative this week, InfoTrie reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ACASTI PHARM-TS earned a news impact score of -3.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutACASTI PHARM-TS.

What is ACASTI PHARM-TS's stock symbol?

ACASTI PHARM-TS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "APO."

How do I buy shares of ACASTI PHARM-TS?

Shares of APO and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.